Clinically formulated with 1% Salmon-derived Polynucleotides and 1% Hyaluronic Acid, this dermal booster increases collagen density by 28.7%* in 8 weeks (per 2023 clinical study). Features 0.3% lidocaine for pain-free administration. FDA-registered manufacturing process ensures pharmaceutical-grade purity.

Key Clinical Advantages

Bioactive Complex Technology

Medical-Grade Packaging

Certified Application Protocol

*Results based on 2023 clinical trial (n=112) by Seoul Dermatology Institute. Must be administered by licensed practitioners. Not a substitute for medical treatment. Storage conditions: 2-8°C protected from light. Batch number verification required before use.Results may vary depending on individual body type.